Myelotoxicity of D-penicillamine.
Open Access
- 1 June 1979
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 38 (3) , 232-236
- https://doi.org/10.1136/ard.38.3.232
Abstract
Information has been collected on 10 patients, 9 with marrow depression and 1 in whom the diagnosis was presumed. Six of the 10 patients died. The sequentially recorded blood counts on at least 5 of the patients showed a downward trend of the white cell and platelet counts while D-penicillamine was still being administered. One patient suddenly developed leucopenia and thrombocytopenia with a streptococcal septicaemia.This publication has 14 references indexed in Scilit:
- Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?BMJ, 1978
- Toxicity of D-penicillamine in rheumatoid arthritisThe American Journal of Medicine, 1978
- FATAL MARROW APLASIA IN PATIENT ON PENICILLAMINEThe Lancet, 1976
- FATAL MARROW APLASIA IN PATIENT ON PENICILLAMINEThe Lancet, 1976
- MARROW APLASIA AND PENICILLAMINEThe Lancet, 1976
- Thrombocytosis in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1976
- FATAL APLASTIC ANÆMIA AND D-PENICILLAMINEThe Lancet, 1976
- D-PENICILLAMINE AND HÆMOLYTIC ANÆMIAThe Lancet, 1976
- Report of SymposiumAnnals of the Rheumatic Diseases, 1975
- Thrombocytosis in Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1972